Efficacy and tolerance of dupilumab in patients with moderate-to-severe atopic dermatitis and obesity

Joséphine Dupuis; Marie Tauber; Emmanuel Mahe; Marie Jachiet; Angèle Soria; Florence Tetart; Eve Puzenat; Justine Pasteur; Nadia Raison-Peyron; Françoise Giordano-Labadie; Catherine Droitcourt; Camille Leleu; Audrey Nosbaum; Hélène Aubert; Marie L.E. Moigne; Claire Bernier; Sébastien Barbarot; Khaled Ezzedine; Emmanuelle Diaz; Thomas Hubiche; Sarah Faiz; Selma Azib; Frederic Dezoteux; Olivier Chosidow; Delphine Staumont-Salle

Article

Efficacy and tolerance of dupilumab in patients with moderate-to-severe atopic dermatitis and obesity

Journal of the European Academy of Dermatology and Venereology

DOI: 10.1111/jdv.20264

4Citations

4Readers

Get full text

Cite

CITATION STYLE

APA

Dupuis, J., Tauber, M., Mahe, E., Jachiet, M., Soria, A., Tetart, F., … Staumont-Salle, D. (2025, February 1). Efficacy and tolerance of dupilumab in patients with moderate-to-severe atopic dermatitis and obesity. Journal of the European Academy of Dermatology and Venereology. John Wiley and Sons Inc. https://doi.org/10.1111/jdv.20264

Efficacy and tolerance of dupilumab in patients with moderate-to-severe atopic dermatitis and obesity

Cite

Register to see more suggestions